Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2001
10/11/2001WO2001074362A1 Inhibition of cyclooxygenase-2 activity
10/11/2001WO2001034572A3 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors
10/11/2001WO2001025210A3 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands
10/11/2001WO2001021714A3 Monoazo dyestuffs useful for colour filters and ink jet printing
10/11/2001WO2001021585A3 Bis(1-aziridino-1-hydroxyiminomethyl)-derivatives, method for the production thereof and use thereof as anti-tumoral agents
10/11/2001US20010029299 Psychological disorders; sleep disorders; anticonvulsants; cognition activators; drug abruse
10/11/2001US20010029263 Alopecia
10/11/2001US20010029261 Alopecia therapy
10/11/2001US20010029258 Partially saturated calcium channel blockers
10/11/2001DE10017539A1 New 6-acylamino-4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors or respiratory or gastrointestinal diseases
10/11/2001CA2405144A1 Ethylenediamine derivatives
10/11/2001CA2404665A1 Novel compounds for enhancing chemotherapy
10/11/2001CA2404592A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/11/2001CA2404386A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2404314A1 Succinoylamino heterocycles as inhibitors of a.beta. protein production
10/11/2001CA2404023A1 Cyclic lactams as inhibitors of a.beta. protein production
10/11/2001CA2403600A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2402705A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2401137A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/10/2001EP1142890A1 Aminopyrazole derivatives
10/10/2001EP1142889A1 Pyrazole derivatives as anti-inflammatory/analgesic agents
10/10/2001EP1142882A1 Acrylonitrile compounds
10/10/2001EP1142879A1 Imidazole compounds and medicinal use thereof
10/10/2001EP1142877A1 2-oxoquinoline compounds and medicinal uses thereof
10/10/2001EP1142587A1 Remedies for pain
10/10/2001EP1140935A2 1,2-annelated quinoline derivatives
10/10/2001EP1140924A1 Piperazine derivatives
10/10/2001EP1140920A1 Piperidines as ccr5 modulators
10/10/2001EP1140914A1 Non-peptide nk1 receptors antagonists
10/10/2001EP1140913A1 Thiourea inhibitors of herpes viruses
10/10/2001EP1140909A1 Novel inhibitors of farnesyl-protein transferase
10/10/2001EP1140908A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140907A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140906A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
10/10/2001EP1140905A1 Heteroaromatic amides as inhibitor of factor xa
10/10/2001EP1140904A1 Farnesyl protein transferase inhibitors
10/10/2001EP1140903A1 Aromatic amides
10/10/2001EP1140902A1 Tricyclic farnesyl protein transferase inhibitors
10/10/2001EP1140901A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
10/10/2001EP1140900A2 Pyrazole compounds and uses thereof
10/10/2001EP1140899A1 Process for preparing tricyclic compounds having antihistaminic activity
10/10/2001EP1140898A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
10/10/2001EP1140897A1 Protease inhibitors
10/10/2001EP1140881A1 Antithrombotic amides
10/10/2001EP1140873A1 Il-5 inhibiting 6-azauracil derivatives
10/10/2001EP1140871A1 Thrombin or factor xa inhibitors
10/10/2001EP1140867A1 New beta-amide and beta-sulfonamide carboxylic acid derivatives, their preparation and their use as endothelin receptor antagonists
10/10/2001EP1140864A2 Vitronectin receptor antagonist pharmaceuticals
10/10/2001EP1140862A1 THROMBIN OR FACTOR Xa INHIBITORS
10/10/2001EP1140860A1 Pyrimidine compounds
10/10/2001EP1140859A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/10/2001EP1140855A1 Tetrahydroindazole derivatives as ligands for gaba-a alpha 5 receptors
10/10/2001EP1140850A1 Quinolinecarboxamides as antiviral agents
10/10/2001EP1140845A1 Susbstituted pyridine herbicides
10/10/2001EP1140840A1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
10/10/2001EP1140839A1 Heterocyclic amides as inhibitors of factor xa
10/10/2001EP1140838A1 1, 4-piperazine derivatives having 5ht1a receptor activity
10/10/2001EP1140836A1 Amide compounds
10/10/2001EP1140835A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
10/10/2001EP1140834A1 Heterocyclic piperidines as modulators of chemokine receptor activity
10/10/2001EP1140833A1 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
10/10/2001EP1140831A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
10/10/2001EP1140830A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5ht1a receptor activity
10/10/2001EP1140828A1 3-azabicyclo[3.1.0]hexane derivatives as opiate receptors ligands
10/10/2001EP1140823A1 Glucagon antagonists/inverse agonists
10/10/2001EP1140822A1 Stable activated novel carbamic acid derivatives, preparation method and use for preparing urea
10/10/2001EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/10/2001EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
10/10/2001EP1140204A2 Vitronectin receptor antagonist pharmaceuticals
10/10/2001EP1140203A2 Vitronectin receptor antagonist pharmaceuticals
10/10/2001EP1140194A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combined treatment of neoplasia
10/10/2001EP1140193A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
10/10/2001EP1140192A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
10/10/2001EP1140183A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
10/10/2001EP1140182A2 Use of a matrix metalloproteinase inhibitor together with an antineoplastic agent, optionally also together with radiation, in the treatment of neoplasia
10/10/2001EP1140179A2 Use of a cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
10/10/2001EP1140178A2 Use of a matrix metallaproteinase inhibitor and radiation as a combined treatment of neoplasia
10/10/2001EP1140177A2 Use of an integrin antagonist and radiation in the treatment of neoplasia
10/10/2001EP1140099A1 Utilisation of 2-substituted 1,2-benzisothiazole derivatives and 3-substituted tetrahydropyridopyrimidinone derivatives for the prophylaxis and therapy of cerebral ischaemia
10/10/2001EP1140087A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
10/10/2001EP1140086A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
10/10/2001EP1140085A1 Azabicycloalkanes as ccr5 modulators
10/10/2001EP1140083A1 Novel compounds
10/10/2001EP1140074A1 Indole and indolizidine derivatives for the treatment of migraine
10/10/2001EP1139972A1 Dihydropyrimidines and uses thereof
10/10/2001EP1139752A1 Methods and compositions for treatment of cell proliferative disorders
10/10/2001EP0832065B1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
10/10/2001EP0770071B1 Sulfonamide derivatives of azolones anti-helicobacter agents
10/10/2001EP0765320B1 Benzimidazolone derivatives with central dopaminergic activity
10/10/2001EP0759907B1 Substituted 3-phenylpyrazoles for use as herbicides
10/10/2001EP0724582B1 Preparation of omeprazole and lansoprazole and intermediates useful therein
10/10/2001CN1316995A Hydroxy 2-pipecolate hydroxamide acid derivatives as MMP inhititors
10/10/2001CN1316993A 4,4-biarylpiperidime derivatives with opioid receptor activity
10/10/2001CN1316991A Azetidine derivatives, preparation and medicines containing them
10/10/2001CN1316426A Uracil compound and its appliance
10/10/2001CN1316424A 1-aryl pyrazole derivative and its applicance
10/10/2001CN1072669C Benzimidazole compounds and their use as modulators of the GABAA receptor complex
10/10/2001CN1072666C (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/09/2001US6300363 Indole compounds as COX-2 inhibitors
10/09/2001US6300360 For therapy of stress related disorders such as post traumatic stress disorder (ptsd) as well as depression, headache and anxiety
1 ... 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 ... 1080